Related Articles
Preoperative serum tissue factor pathway inhibitor‑2 level as a prognostic marker for endometrial cancer
Expression of ELF5 in endometrial carcinoma tissues and its clinical significance
Coexistence of adenomyosis, adenocarcinoma, endometrial and myometrial lesions in resected uterine specimens
Molecular determinants for lymph node metastasis in clinically early-stage endometrial cancer
Expression of MIF and c-erbB-2 in endometrial cancer